Literature DB >> 21965268

Elevated LET components in clinical proton beams.

C Grassberger1, H Paganetti.   

Abstract

This paper assesses the contribution of secondary particles to pencil and passively scattered proton beams, in particular when considering the dose-averaged linear energy transfer (LET(d)) in biological treatment planning. Proton Monte Carlo simulations are performed in water phantoms and for two patients, considering all primary and secondary particles, including recoils from inelastic nuclear interactions. Our results show that secondary protons exhibit LET(d) values up to a factor 10 higher than those of the primary protons at the same depth. Thus, secondary protons have a significant impact on the LET(d). Their contribution increases the LET(d) by ∼50% along the central axis and even >200% in the penumbra. Furthermore, the LET maximum after the peak changes from 12 to 15 keV µm(-1) when adding secondary protons to the primary contribution. This is important when modeling LET(d) with analytical methods. The contribution of recoils (A > 3) is observed to be 1.2% in the entrance region considering a prostate case. The degree of biological damage inflicted by recoils remains hard to quantify, but is discussed on the basis of detailed energy spectra. The results highlight the role of secondary protons in LET-based radiobiological effectiveness calculations for proton therapy and when analyzing radiobiological experiments. Furthermore, the findings demonstrate the impact of inhomogeneities on the LET and the subtle changes between the LET distributions of passively scattered and actively scanned beams.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21965268     DOI: 10.1088/0031-9155/56/20/011

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  27 in total

1.  Analysis of the track- and dose-averaged LET and LET spectra in proton therapy using the geant4 Monte Carlo code.

Authors:  Fada Guan; Christopher Peeler; Lawrence Bronk; Changran Geng; Reza Taleei; Sharmalee Randeniya; Shuaiping Ge; Dragan Mirkovic; David Grosshans; Radhe Mohan; Uwe Titt
Journal:  Med Phys       Date:  2015-11       Impact factor: 4.071

2.  Intensity modulated proton therapy.

Authors:  H M Kooy; C Grassberger
Journal:  Br J Radiol       Date:  2015-05-27       Impact factor: 3.039

3.  Investigation of EBT2 and EBT3 films for proton dosimetry in the 4-20 MeV energy range.

Authors:  S Reinhardt; M Würl; C Greubel; N Humble; J J Wilkens; M Hillbrand; A Mairani; W Assmann; K Parodi
Journal:  Radiat Environ Biophys       Date:  2015-01-09       Impact factor: 1.925

Review 4.  Treatment planning for proton therapy: what is needed in the next 10 years?

Authors:  Hakan Nystrom; Maria Fuglsang Jensen; Petra Witt Nystrom
Journal:  Br J Radiol       Date:  2019-08-07       Impact factor: 3.039

5.  Extension of TOPAS for the simulation of proton radiation effects considering molecular and cellular endpoints.

Authors:  Lisa Polster; Jan Schuemann; Ilaria Rinaldi; Lucas Burigo; Aimee L McNamara; Robert D Stewart; Andrea Attili; David J Carlson; Tatsuhiko Sato; José Ramos Méndez; Bruce Faddegon; Joseph Perl; Harald Paganetti
Journal:  Phys Med Biol       Date:  2015-06-10       Impact factor: 3.609

6.  TOPAS: an innovative proton Monte Carlo platform for research and clinical applications.

Authors:  J Perl; J Shin; J Schumann; B Faddegon; H Paganetti
Journal:  Med Phys       Date:  2012-11       Impact factor: 4.071

7.  Linear energy transfer incorporated intensity modulated proton therapy optimization.

Authors:  Wenhua Cao; Azin Khabazian; Pablo P Yepes; Gino Lim; Falk Poenisch; David R Grosshans; Radhe Mohan
Journal:  Phys Med Biol       Date:  2017-12-19       Impact factor: 3.609

8.  Nanoscale measurements of proton tracks using fluorescent nuclear track detectors.

Authors:  Gabriel O Sawakuchi; Felisberto A Ferreira; Conor H McFadden; Timothy M Hallacy; Dal A Granville; Narayan Sahoo; Mark S Akselrod
Journal:  Med Phys       Date:  2016-05       Impact factor: 4.071

9.  Robust intensity-modulated proton therapy to reduce high linear energy transfer in organs at risk.

Authors:  Yu An; Jie Shan; Samir H Patel; William Wong; Steven E Schild; Xiaoning Ding; Martin Bues; Wei Liu
Journal:  Med Phys       Date:  2017-10-26       Impact factor: 4.071

10.  Proton Relative Biological Effectiveness - Uncertainties and Opportunities.

Authors:  Harald Paganetti
Journal:  Int J Part Ther       Date:  2018-09-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.